Log In
Print
BCIQ
Print
Print this Print this
 

Epanova

  Manage Alerts
Collapse Summary General Information
Company Chrysalis Pharma AG
DescriptionUltra-pure mixture of the free fatty acid forms of eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA)
Molecular Target
Mechanism of Action 
Latest Stage of DevelopmentPhase III
IndicationHypertriglyceridemia
Partner

Omthera Pharmaceuticals Inc.
 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today